The global adhesion barrier market size was estimated at USD 602.36 million in 2017 and is estimated to expand at a CAGR of 7.1% over the forecast period. Growing geriatric population, along with rising number of surgeries and sports-related injuries, is anticipated to drive the market. Rising cases of chronic diseases, such as cancer and neurological, gynecological, ophthalmic, and dental disorders, are also projected to contribute toward the market demand.
The treatment of these diseases requires surgical procedures, and microsurgery in certain cases, which is boosting the demand for adhesion barriers. For instance, the prevalence of cancer is rising, as per the statistics published by the World Health Organization (WHO). Approximately 8.2 million die each year from cancer, which accounts for 13.0% deaths worldwide.
It is also anticipated that there will be a 70.0% increase in the disease occurrence over the next couple of decades and over 100 types of cancer exist, which require unique therapy. In addition, as per the data published by WHO, currently over 50 million people suffer from epileptic seizures. It is estimated that 2.4 million people of the global population will be diagnosed with epilepsy every year.
Along with these disorders, increasing incidences of paralysis and spinal injuries are also contributing toward the market growth. According to a report published by Christopher & Dana Reeve Foundation Paralysis Resource Center in 2012, the leading causes for the increasing occurrence of paralysis include stroke (29.0%), spinal cord injury (23.0%), and multiple sclerosis (17.0%).
Thus, rising cases of neurological disorders is also supporting the growth of this market. Along with the above-mentioned disorders, adhesion barriers have critical applications in ENT, ophthalmic, and gynecologic disorders. Such conditions require surgeries, which is anticipated to augment the market demand in the coming years.
On the basis of product, the market is segmented into synthetic and natural adhesion barrier. The synthetic adhesion barriers segment was the largest segment in 2017, accounting for over 50.0% of the market in 2017. This market share may be attributed to the cost-effectiveness of synthetic adhesion barrier as compared to the natural adhesion barrier.
Synthetic adhesion barrier market has been further segmented into hyaluronic acid, regenerated cellulose, polyethylene glycol, and others. Polyethylene glycol based adhesion barrier is anticipated to witness the fastest growth over the forecast period owing to its properties of absorbability and biocompatibility. The most commonly used polyethylene glycol based adhesion barriers are SprayGel and SprayShield, manufactured by Medtronic. It is, generally, used in the post-operative gynecologic and general surgery procedures.
On the basis of application, the market is segmented into gynecological surgeries, abdominal general surgeries, orthopedic surgeries, cardiovascular surgeries, neurological surgeries, urological surgeries, and others. The cardiovascular surgeries segment is anticipated to witness the fastest growth over the forecast period. This is mainly due to the rising geriatric population base and changing lifestyle leading to the rising prevalence of cardiovascular diseases (CVDs).
On the basis of formulation, the market has been segmented into film/mesh, gel, and liquid. In 2017, the film/mesh formulated adhesion barrier led the industry and held around 44.0% of the global share. This market share may be attributed to the ease of use of mesh adhesion barriers in post-operative procedures.
The gel formulated adhesion barrier is anticipated to witness fastest growth with a CAGR of 7.5%, over the forecast period. Adhesion barrier gels are composed of polyethylene oxide and sodium carboxy methylcellulose, with protective activity. It prevents the formation of post-surgical intrauterine adhesions. DYNAVISC, Betamix, and Oxiplex/AP are some of the commonly used adhesion barrier gels.
In terms of region, North America led the market in 2017 and is anticipated to witness the same trend over the foreseeable future. This growth can be attributed to the presence of a large number key companies in the North America region. Moreover, rising demand for technologically advanced healthcare facilities is also boosting the region’s growth. Increasing population and cases of CVDs in Asia Pacific is expected to drive the regional market.
Developing countries such as China, India, and Japan are anticipated to offer the maximum growth opportunities for the Asia Pacific regional market. Rapidly growing medical tourism industry in these countries will fuel the demand for adhesion barriers in this region. For instance, as per a report on the Export Health Services by the Directorate-General of Commercial Intelligence and Statistics of India, in 2015-2016, India had 58,300 medical tourists on medical visas.
Some of the key companies in the global market are Johnson & Johnson; Sanofi S.A.; Baxter International, Inc.; Becton, Dickinson and Company; Integra LifeSciences Holdings Corporation; Anika Therapeutics, Inc.; Atrium Medical Corporation (A Part of Getinge Group); FzioMed, Inc.; MAST Biosurgery, Inc.; and Innocoll Holdings PLC. New product launch, partnerships, and M&A activities are the major strategies adopted by most of these market players to increase their market share.
For instance, in December 2017, Becton Dickinson and Company completed the acquisition of C.R. Bard. According to the former company, this acquisition helped strengthen their product portfolio.
Base year for estimation
Actual estimates/Historical data
2015 - 2016
2018 - 2026
Revenue in USD Million & CAGR from 2018to 2026
North America, Europe, Asia Pacific, Latin America, MEA
Revenue forecast, company share, competitive landscape, growth factors and trends
U.S., Canada, U.K., Germany, France, Italy, Spain, Switzerland, Netherlands, Greece, Japan, China, India, Australia, Singapore, Malaysia, Russia, New Zealand, Vietnam, Hong Kong, Brazil, Mexico, Argentina, Colombia, Costa Rica, South Africa, Saudi Arabia, Oman, UAE, Egypt
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global adhesion barrier market report on the basis of product, formulation, application, and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Collagen & Protein
Formulation Outlook (Revenue, USD Million, 2015 - 2026)
Application Outlook (Revenue, USD Million, 2015 - 2026)
Abdominal General Surgeries
Regional Outlook (Revenue, USD Million, 2015 - 2026)
Middle East & Africa (MEA)
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."